[Problems of development, production and clinical use of highly effective blood substitutes].
An analysis of biological properties of blood substitutes has shown the expedience of wider clinical use instead of polyglucin of such substitutes as polyglucol, polifer, rondex, neorondex, polyoxidin, volecam; instead of rheopolyglucin--the rheopolyglucin with glucose, rheogluman and rheoglusol prepared for clinical tests; instead of haemodesin--haemodesin-H, neohaemodesin, gluconeodesin; instead of protein hydrolysates--polyamine and purified from peptides infusamine, hydromine, amicin; instead of 0.9% solution of sodium chloride--disol, quintasol, lactasol, mafusol. They have polyfunctional properties and considerably increase the effectiveness of the infusion--transfusion therapy.
Merzlov
V P
VP
Khliabich
K G
KG
Chernenko
G T
GT
D001802:Blood Substitutes / Q000592:standards / Q000627:therapeutic use; D003911:Dextrans / Q000592:standards / Q000627:therapeutic use; D004338:Drug Combinations; D005561:Formates / Q000592:standards / Q000627:therapeutic use; D006801:Humans; D008353:Mannitol / Q000592:standards / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000592:standards / Q000627:therapeutic use; D011205:Povidone / Q000592:standards / Q000627:therapeutic use
D001802:Blood Substitutes; D003911:Dextrans; D004338:Drug Combinations; D005561:Formates; D010952:Plasma Substitutes; C024634:rheogluman; C030544:formic acid; D008353:Mannitol; C007918:hemodes; D011205:Povidone